IP Library › Granted Patent US 12,336,888
Granted Patent B2
US 12,336,888 · App. 17/999,102 · Granted Jun 24, 2025

Negative pressure wound therapy (NPWT) dressing

Inventors: Malin Svensson (Gothenburg, SE); Viktoria Skeppstedt (Västra Frölunda, SE); Malin Holmén (Gothenburg, SE); Elinor Bolyos (Landvetter, SE)
Assignee: Mölnlycke Health Care AB
A61F13/05A61F13/0223A61M1/985
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,336,888
App. No.
17/999,102
Granted
Jun 24, 2025
Kind
B2
Abstract

Described is a negative wound therapy (NPWT) dressing that includes a backing layer and an adhesive skin contact layer, the adhesive skin contact layer being configured to detachably adhere the dressing to a dermal surface, wherein the backing layer includes a coupling member. The coupling member includes a tubing configured to connect the dressing to a negative pressure source and to a remote fluid collector.

Claims (38)

1. A negative pressure wound therapy (NPWT) system comprising:

a dressing comprising:

a backing layer comprising a coupling member, wherein the coupling member comprises tubing, wherein the tubing defines:

a fluid conduit configured to remove fluid from said dressing; and

an air conduit configured to supply air to said fluid conduit and/or said dressing,

an adhesive skin contact layer,

an absorbent structure arranged between said backing layer and said adhesive skin contact layer, wherein the absorbent structure comprises:

a superabsorbent layer; and

at least one additional liquid spreading layer, and

a liquid spreading layer arranged between said absorbent structure and said backing layer;

wherein said adhesive skin contact layer being configured to detachably adhere the dressing to a dermal surface,

a NPWT device comprising:

a pump;

a remote fluid collection canister fluidly connected to said pump; and

a battery operably coupled to the pump; and

a length of tubing extending between a second connector portion and the NPWT device and fluidly coupling the pump and the remote fluid collection canister to the dressing,

wherein the system is configured to receive an amount of liquid at the adhesive skin contact layer of the dressing during use, wherein the system is configured to distribute the amount of liquid between the dressing and the remote fluid collection canister such that at least 39%, but no more than 60% of the amount of liquid is collected by the remote fluid collection canister following 7 days of operation of the system with a negative pressure of −125 mmHg applied to the dressing.

2. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein said backing layer and at least a portion of said absorbent structure each comprises an opening; said opening of each of said absorbent structure and said backing layer being arranged underneath said coupling member, wherein said liquid spreading layer is void of an opening.

3. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein said liquid spreading layer is a configured to extend across at least 90% of a surface area of the absorbent structure.

4. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein said liquid spreading layer is a hydrophilic and porous layer.

5. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein said liquid spreading layer comprises a nonwoven.

6. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein said absorbent structure comprises superabsorbent particles in an amount of from 10 to 20 mg/cm 2 .

7. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein the at least one additional liquid spreading layer comprises a first liquid spreading layer and a second liquid spreading layer, wherein said superabsorbent layer is arranged between said first and said second liquid spreading layers.

8. The negative pressure wound therapy (NPWT) system according to claim 7 , wherein the first and second liquid spreading layers are in contact with the superabsorbent layer.

9. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein said absorbent structure is embossed.

10. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein said backing layer and said adhesive skin contact layer are configured to extend beyond a periphery of said absorbent structure to form a border portion along a contour of said absorbent structure, wherein said adhesive skin contact layer comprises a plurality of apertures in an area underlying said absorbent structure, but is void of apertures in an area forming said border portion.

11. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein said backing layer has a moisture vapor transmission rate (MVTR) in the range of from 500 to 3500 g/m 2 /24 h, as measured by NWSP070.4R0(15).

12. A kit comprising a negative pressure wound therapy (NPWT) system according to claim 1 , and adhesive strip(s).

13. The negative pressure wound therapy (NPWT) system according to claim 1 ,

wherein said dressing further comprises:

a transmission layer arranged between said adhesive skin contact layer and said absorbent structure; and

a plurality of adhesive stripes between said absorbent structure and said transmission layer, wherein the adhesive stripes are configured to inhibit a flow of exudate towards the coupling member,

wherein said transmission layer comprises a spacer fabric.

14. The negative pressure wound therapy (NPWT) system according to claim 13 , wherein the plurality of adhesive stripes are arranged orthogonal to a flow path of exudate towards the coupling member.

15. The negative pressure wound therapy (NPWT) system according to claim 13 , wherein the plurality of adhesive stripes comprise between two and six adhesive stripes.

16. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein the coupling member comprises a first connector portion coupled to the fluid conduit and the air conduit, wherein the system further comprises the second connector portion detachably connected to said first connector portion to form a connector unit, wherein the second connector portion of the connector unit defines an air entry in communication with the air conduit, wherein the length of tubing extends between the second connector portion and the NPWT device.

17. The negative pressure wound therapy (NPWT) system according to claim 16 , wherein the system is configured to supply air to said dressing at a rate of from 2 to 7 ml/min during operation.

18. The negative pressure wound therapy (NPWT) system according to claim 1 , wherein the NPWT device is configured to be carried by a user during use.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF ASSIGNEE PREVIOUSLY RECORDED ON REEL 62257 FRAME 515. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 15, 2024
From: SVENSSON, MALIN; SKEPPSTEDT, VIKTORIA; HOLMEN, MALIN; BOLYOS, ELINOR
To: MOLNLYCKE HEALTH CARE AB
Reel/Frame 069479/0841 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2023
From: SVENSSON, MALIN; SKEPPSTEDT, VIKTORIA; HOLMEN, MALIN; BOLYOS, ELINOR
To: MOLYLYCKE HEALTH CARE AB
Reel/Frame 062257/0515 →
Priority Claims (1)
EP 20176287 · May 25, 2020 · regional
Continuity (1)
Related Publication 20230210699A1 · Jul 6, 2023
References Cited (85)
US 5403304A · Ishida · 1995 [cited by applicant]
US 9795724B2 · Whyte et al. · 2017 [cited by applicant]
US 9877872B2 · Mumby et al. · 2018 [cited by applicant]
US 10231878B2 · Hartwell et al. · 2019 [cited by applicant]
US 11738136B2 · Nilsson et al. · 2023 [cited by applicant]
US 20050080372A1 · Nielsen · 2005 [cited by applicant]
US 20050182347A1 · Bishop et al. · 2005 [cited by applicant]
US 20090177135A1 · Rogers et al. · 2009 [cited by applicant]
US 20100305490A1 · Coulthard et al. · 2010 [cited by applicant]
US 20120116334A1 · Albert · 2012 [cited by examiner]
US 20120271257A1 · Coulthard et al. · 2012 [cited by applicant]
US 20130172843A1 · Kurata · 2013 [cited by examiner]
US 20140276490A1 · Locke et al. · 2014 [cited by applicant]
US 20140171888A1 · Croizat · 2014 [cited by applicant]
US 20140249495A1 · Mumby et al. · 2014 [cited by applicant]
US 20150051560A1 · Askem · 2015 [cited by applicant]
US 20160030722A1 · Anderson et al. · 2016 [cited by applicant]
US 20160262942A1 · Riesinger et al. · 2016 [cited by applicant]
US 20160339226A1 · Sealfon · 2016 [cited by applicant]
US 20170143552A1 · Hartwell et al. · 2017 [cited by applicant]
US 20170189236A1 · Locke · 2017 [cited by examiner]
US 20180243139A1 · Szypka · 2018 [cited by examiner]
US 20190015258A1 · Gowans · 2019 [cited by examiner]
US 20190151159A1 · Gowans · 2019 [cited by examiner]
US 20190298579A1 · Moore et al. · 2019 [cited by applicant]
US 20200085632A1 · Locke · 2020 [cited by applicant]
US 20200337906A1 · Long · 2020 [cited by examiner]
US 20210113748A1 · Rice · 2021 [cited by examiner]
US 20210137743A1 · Hartwell et al. · 2021 [cited by applicant]
US 20210187171A1 · Collinson · 2021 [cited by examiner]
US 20210196525A1 · Bishop · 2021 [cited by examiner]
US 20220001212A1 · Bass · 2022 [cited by examiner]
US 20220047799A1 · Quintanar · 2022 [cited by examiner]
US 20220226559A1 · Locke · 2022 [cited by examiner]
CN 103841935 · 2014 [cited by applicant]
CN 103841935A · 2014 [cited by applicant]
CN 103857365 · 2014 [cited by applicant]
CN 109937056 · 2019 [cited by applicant]
DE 102012223399 · 2014 [cited by applicant]
EP 0214867 · 1991 [cited by applicant]
EP 0541251 · 1993 [cited by applicant]
EP 2253294 · 2010 [cited by applicant]
EP 2529765 · 2013 [cited by applicant]
EP 3320926 · 2018 [cited by applicant]
EP 3320926A1 · 2018 [cited by applicant]
GB 0225544 · 2002 [cited by applicant]
GB 2380945A · 2002 [cited by applicant]
WO WO9608223 · 1996 [cited by applicant]
WO WO1996008223 · 1996 [cited by applicant]
WO WO2004037334 · 2004 [cited by applicant]
WO WO2007051599 · 2007 [cited by applicant]
WO WO2007113597 · 2007 [cited by applicant]
WO WO2008027449 · 2008 [cited by applicant]
WO WO2010141030 · 2010 [cited by applicant]
WO WO2011087871 · 2011 [cited by applicant]
WO WO2012156655 · 2012 [cited by applicant]
WO WO2013007973 · 2013 [cited by applicant]
WO WO2013015827 · 2013 [cited by applicant]
WO WO2013029652 · 2013 [cited by applicant]
WO WO2015188003 · 2015 [cited by applicant]
WO WO2016079037 · 2016 [cited by applicant]
WO WO2017040074 · 2017 [cited by applicant]
WO WO2017087163 · 2017 [cited by applicant]
WO WO2017196888 · 2017 [cited by applicant]
WO WO2018086876 · 2018 [cited by applicant]
WO WO2018158250 · 2018 [cited by applicant]
WO WO2018231815 · 2018 [cited by applicant]
WO WO2019040729 · 2019 [cited by applicant]
WO WO2019084087 · 2019 [cited by applicant]
WO WO2019089944 · 2019 [cited by applicant]
WO WO2019129581 · 2019 [cited by applicant]
WO WO2019171351 · 2019 [cited by applicant]
WO WO2020011691 · 2020 [cited by applicant]
WO WO2020055945 · 2020 [cited by applicant]
WO WO2020078993 · 2020 [cited by applicant]
WO WO2020102214 · 2020 [cited by applicant]
WO WO2021239652 · 2021 [cited by applicant]
WO WO2021239653 · 2021 [cited by applicant]
WO WO2021239660 · 2021 [cited by applicant]
WO WO2021239661 · 2021 [cited by applicant]
International Search Report and Written Opinion were mailed on Jul. 22, 2021 by the International Searching Authority for International Application No. PCT/EP2021/063756 filed on May 24, 2021 and published as WO20212396… [cited by applicant]
International Search Report and Written Opinion were mailed on Aug. 17, 2021 by the International Searching Authority for International Application No. PCT/EP2021/063755 filed on May 24, 2021 and published as WO 2021-23… [cited by applicant]
International Search Report and Written Opinion were mailed on Aug. 17, 2021 by the International Searching Authority for International Application No. PCT/EP2021/063748 filed on May 24, 2021 and published as WO20212396… [cited by applicant]
International Search Report and Written Opinion were mailed on Sep. 10, 2021 by the International Searching Authority for International Application No. PCT/EP2021/063747 filed on May 24, 2021 and published as WO20212396… [cited by applicant]
Notice of Opposition was issued for European Application No. 20176254.9 by the European Patent Office on Nov. 26, 2024 (40 pages). [cited by applicant]